A Content Analysis of Vaping Advertisements on Twitter, November 2014.
BACKGROUND
Vaping has increased in popularity, and the potential harms and benefits are largely unknown. Vaping-related advertising is expected to grow as the vaping industry grows; people are exposed primarily to vaping advertisements on the Internet, and Twitter is an especially popular social medium among young people. The primary objective of our study was to describe the characteristics of vaping-related advertisements on Twitter.


METHODS
We collected data on 403,079 English-language tweets that appeared during November 2014 and contained vaping-related keywords. Using crowdsourcing services, we identified vaping-related advertisements in a random sample of 5,000 tweets. The advertisement tweets were qualitatively coded for popular marketing tactics by our research team. We also inferred the demographic characteristics of followers of 4 Twitter handles that advertised various novel vape products.


RESULTS
The random sample of 5,000 vaping-related tweets included 1,156 (23%) advertisement tweets that were further analyzed. Vape pens were advertised in nearly half of the advertisement tweets (47%), followed by e-juice (21%), which commonly mentioned flavors (42%). Coupons or price discounts were frequently observed (32%); only 3% of tweets mentioned vaping as a way to quit smoking or as an alternative to smoking. One handle had a disproportionately high percentage of racial/ethnic minority followers.


CONCLUSIONS
Vaping poses a threat to smoking prevention progress, and it is important for those in tobacco control to understand and counter the tactics used by vaping companies to entice their consumers, especially on social media where young people can easily view the content.
Department of Psychiatry, Washington University School of Medicine, 660 S Euclid Ave, Box 8134, St. Louis, MO 63110. Email: sowless@psychiatry.wustl.edu.
Shaina J
SJ
Sowles
Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.
Melissa J
MJ
Krauss
Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.
Sarah
S
Connolly
Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.
Patricia A
PA
Cavazos-Rehg
JAMA. 2014 Aug 13;312(6):595-6
24979277
PLoS One. 2013 Jun 24;8(6):e66317
23826093
Pediatrics. 2015 Nov;136(5):1008-17
26504137
Tob Control. 2016 Dec;25(e2):e107-e112
26781305
Subst Abus. 2014;35(2):127-8
24821347
JAMA. 2014 Dec 17;312(23):2493-4
25383564
Ther Adv Drug Saf. 2014 Apr;5(2):67-86
25083263
Tob Control. 2014 Jul;23 Suppl 3:iii26-30
24935894
Nicotine Tob Res. 2015 Oct;17(10):1195-202
25381306
Addict Behav. 2016 May;56:41-50
26803400
Lancet. 2013 Nov 16;382(9905):1629-37
24029165
Fed Regist. 2016 May 10;81(90):28973-9106
27192730
Neuropharmacology. 2014 Jan;76 Pt B:416-24
23954491
Ther Adv Respir Dis. 2016 Apr;10 (2):130-5
26668136
Prev Chronic Dis. 2015 Jul 30;12:E121
26226068
Tob Control. 2002 Mar;11 Suppl 1:I62-72
11893816
Am J Public Health. 2015 Jun;105(6):e16-21
25880960
J Adolesc Health. 2015 Feb;56(2):139-45
25620299
JAMA. 2015 Aug 18;314(7):700-7
26284721
Addict Sci Clin Pract. 2012 Apr 19;7:5
23186143
Tob Control. 2014 Jul;23 Suppl 3:iii41-7
24935898
Int J Drug Policy. 2016 Oct;36:141-7
26992484
N Engl J Med. 2015 Jan 22;372(4):392-4
25607446
Tob Control. 2014 May;23 Suppl 2:ii4-10
24732162
JAMA Pediatr. 2015 Mar;169(3):e1563
25730697